Search Results - Reinhard Dummer

Refine Results
  1. 1

    Immunological effects of BRAF+MEK inhibition by Paolo A. Ascierto, Reinhard Dummer

    Published in OncoImmunology (2018-09-01)
    Get full text
    Article


  2. 2

    The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemur... by Reinhard Dummer, Michèle Welti, Egle Ramelyte

    Published in Journal of Translational Medicine (2023-08-01)
    Get full text
    Article


  3. 3

    Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma by Claudia C. V. Lang, Claudia C. V. Lang, Egle Ramelyte, Egle Ramelyte, Reinhard Dummer, Reinhard Dummer

    Published in Frontiers in Oncology (2020-08-01)
    Get full text
    Article


  4. 4

    Data mining The Cancer Genome Atlas in the era of precision cancer medicine by Phil F. Cheng, Reinhard Dummer, Mitchell P Levesque

    Published in Swiss Medical Weekly (2015-09-01)
    Get full text
    Article


  5. 5

    Flare-Up of Rheumatoid Arthritis by Anti-CTLA-4 Antibody but Not by Anti-PD1 Therapy in a Patient with Metastatic Melanoma by Nicoletta F. Jaberg-Bentele, Michael Kunz, Shatha Abuhammad, Reinhard Dummer

    Published in Case Reports in Dermatology (2017-03-01)
    Get full text
    Article


  6. 6

    Cutaneous adverse events of pan-RAF inhibitor naporafenib (LXH254) containing drug combinations in NRAS-mutant metastatic melanoma by Sabine Hoheisel, Jacopo Roggero, Joanna Mangana, Reinhard Dummer, Lukas Kraehenbuehl, Egle Ramelyte

    Published in EJC Skin Cancer (2025-01-01)
    Get full text
    Article


  7. 7

    Evolving impact of long-term survival results on metastatic melanoma treatment by Olivier Michielin, Paolo Antonio Ascierto, Reinhard Dummer, Michael B Atkins, Henry B Koon

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  8. 8

    Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids by Reinhard Dummer, Joanna Mangana, Egle Ramelyte, Achim Weber, Elias Burri, Phil F Cheng, Alia Schneider

    Published in Journal for ImmunoTherapy of Cancer (2024-07-01)
    Get full text
    Article


  9. 9

    Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis by Lukas Kraehenbuehl, Stephanie Schneider, Laura Pawlik, Joanna Mangana, Phil Cheng, Reinhard Dummer, Barbara Meier-Schiesser

    Published in Pharmaceuticals (2023-06-01)
    Get full text
    Article


  10. 10

    Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation by Ulf Guendisch, Benjamin Loos, Phil F. Cheng, Reinhard Dummer, Mitchell P. Levesque, Sandra Varum, Lukas Sommer

    Get full text
    Article


  11. 11

    Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor‐related myocarditis and myositis: rechallenge? by Valentina A. Rossi, Joanna Gawinecka, Florentia Dimitriou, Arnold vonEckardstein, Reinhard Dummer, Frank Ruschitzka, Christian M. Matter

    Published in ESC Heart Failure (2023-08-01)
    Get full text
    Article


  12. 12

    Correction: RASopathic Skin Eruptions during Vemurafenib Therapy. by Jeannine D. Rinderknecht, Simone M. Goldinger, Sima Rozati, Jivko Kamarashev, Katrin Kerl, Lars E. French, Reinhard Dummer, Benedetta Belloni

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  13. 13

    NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5 by Selina Gurri, Beat Siegenthaler, Michael Cangkrama, Gaetana Restivo, Marcel Huber, James Saliba, Reinhard Dummer, Volker Blank, Daniel Hohl, Sabine Werner

    Published in EMBO Molecular Medicine (2023-10-01)
    Get full text
    Article


  14. 14

    Swiss Recommendations for Systemic Therapies in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma by Mirijam Nägeli, Joanna Mangana, Roger von Moos, Lukas Flatz, Robert E. Hunger, Rastine Merat, Olivier Gaide, Marco Siano, Reinhard Dummer

    Published in healthbook TIMES. Oncology Hematology (2021-06-01)
    Get full text
    Article


  15. 15

    A paracrine activin A–mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming by Michael Cangkrama, Mateusz Wietecha, Nicolas Mathis, Rin Okumura, Luca Ferrarese, Dunja Al‐Nuaimi, Maria Antsiferova, Reinhard Dummer, Metello Innocenti, Sabine Werner

    Published in EMBO Molecular Medicine (2020-03-01)
    Get full text
    Article


  16. 16

    Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with TwoState-of-the-Art Techniques by Nicola L. Schoenewolf, Reinhard Dummer, Daniela Mihic-Probst, Holger Moch, Mathew Simcock, Adrian Ochsenbein, Silke Gillessen, Peter Schraml, Roger von Moos

    Published in Case Reports in Oncology (2012-06-01)
    Get full text
    Article


  17. 17

    Lung Nodules in Melanoma Patients: Morphologic Criteria to Differentiate Non-Metastatic and Metastatic Lesions by Simone Alexandra Stadelmann, Christian Blüthgen, Gianluca Milanese, Thi Dan Linh Nguyen-Kim, Julia-Tatjana Maul, Reinhard Dummer, Thomas Frauenfelder, Matthias Eberhard

    Published in Diagnostics (2021-05-01)
    Get full text
    Article


  18. 18

    Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation by Tom Hartwig, Pascale Zwicky, Bettina Schreiner, Nikhil Yawalkar, Phil Cheng, Alexander Navarini, Reinhard Dummer, Lukas Flatz, Curdin Conrad, Christoph Schlapbach, Burkhard Becher

    Published in Cell Reports (2018-12-01)
    Get full text
    Article


  19. 19

    Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases by Nina Zila, Andrea Bileck, Besnik Muqaku, Lukas Janker, Ossia M. Eichhoff, Phil F. Cheng, Reinhard Dummer, Mitchell P. Levesque, Christopher Gerner, Verena Paulitschke

    Published in Clinical Proteomics (2018-03-01)
    Get full text
    Article


  20. 20

    Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. <i>Non-Coding RNA</i> 2021, <i>7</i>, 5 by Marina Tusup, Phil F. Cheng, Ernesto Picardi, Austeja Raziunaite, Reinhard Dummer, Mitchell P. Levesque, Lars E. French, Emmanuella Guenova, Thomas M. Kundig, Steve Pascolo

    Published in Non-Coding RNA (2022-11-01)
    Get full text
    Article


Search Tools: